Literature DB >> 19468992

Gastrointestinal lesions associated with spondyloarthropathies.

Ambrogio Orlando1, Sara Renna, Giovanni Perricone, Mario Cottone.   

Abstract

Subclinical gut inflammation has been described in up to two-thirds of patients with spondyloarthropathies (SpA). Arthritis represents an extra-intestinal manifestation of several gastrointestinal diseases, including inflammatory bowel disease (IBD), Whipple's disease, Behcet's disease, celiac disease, intestinal bypass surgery, parasitic infections of the gut and pseudomembranous colitis. Moreover about two-thirds of nonsteroidal anti-inflammatory drug users demonstrate intestinal inflammation. Arthritis may manifest as a peripheral or axial arthritis. The spondyloarthropathy family consists of the following entities: ankylosing spondylitis, undifferentiated spondyloarthritis, reactive arthritis, psoriatic arthritis, spondyloarthritis associated with IBD, juvenile onset spondyloarthritis. This topic reviews the major gastrointestinal manifestations that can occur in patients with SpA and in nonsteroidal anti-inflammatory drugs users.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468992      PMCID: PMC2686900          DOI: 10.3748/wjg.15.2443

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  46 in total

Review 1.  The gut in the spondyloarthropathies.

Authors:  H Mielants; E M Veys
Journal:  J Rheumatol       Date:  1990-01       Impact factor: 4.666

2.  Arthritis and enteritis--an interface of protean manifestations.

Authors:  R D Inman
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

3.  [Criteria of the classification of spondylarthropathies].

Authors:  B Amor; M Dougados; M Mijiyawa
Journal:  Rev Rhum Mal Osteoartic       Date:  1990-02

4.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

5.  Psoriatic arthritis (PSA)--an analysis of 220 patients.

Authors:  D D Gladman; R Shuckett; M L Russell; J C Thorne; R K Schachter
Journal:  Q J Med       Date:  1987-02

Review 6.  Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease.

Authors:  B Schorr-Lesnick; L J Brandt
Journal:  Am J Gastroenterol       Date:  1988-03       Impact factor: 10.864

7.  Characterization of uveitis associated with spondyloarthritis.

Authors:  J T Rosenbaum
Journal:  J Rheumatol       Date:  1989-06       Impact factor: 4.666

8.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs.

Authors:  M C Allison; A G Howatson; C J Torrance; F D Lee; R I Russell
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

9.  Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.

Authors:  M D Smith; R A Gibson; P M Brooks
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

10.  Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.

Authors:  M J Langman; L Morgan; A Worrall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02
View more
  12 in total

1.  NSAID-induced deleterious effects on the proximal and mid small bowel in seronegative spondyloarthropathy patients.

Authors:  Mihai Rimbaş; Mădălina Marinescu; Mihail Radu Voiosu; Cristian Răsvan Băicuş; Simona Caraiola; Adriana Nicolau; Doina Niţescu; Georgeta Camelia Badea; Magda Ileana Pârvu
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

2.  Mucosal inflammation in spondylarthritides: past, present, and future.

Authors:  Liesbet Van Praet; Filip Van den Bosch; Herman Mielants; Dirk Elewaut
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

3.  Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis.

Authors:  A Shukla; P Gaur; A Aggarwal
Journal:  Clin Exp Immunol       Date:  2016-09       Impact factor: 4.330

4.  Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential.

Authors:  Deena L Gibbons; Lucie Abeler-Dörner; Tim Raine; Il-Young Hwang; Anett Jandke; Melanie Wencker; Livija Deban; Christopher E Rudd; Peter M Irving; John H Kehrl; Adrian C Hayday
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

5.  Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration.

Authors:  A Aggarwal; A N Sarangi; P Gaur; A Shukla; R Aggarwal
Journal:  Clin Exp Immunol       Date:  2016-12-12       Impact factor: 4.330

6.  Gastrointestinal manifestations in systemic autoimmune diseases.

Authors:  M Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2011-01

7.  Inflammatory bowel disease-associated spondyloarthropathies.

Authors:  Walter Fries
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

8.  Nutritional supplementation and dietary restriction in the resolution of enthesitis-related arthritis.

Authors:  Stephen J Genuis; Anna-Kristen J Siy
Journal:  JRSM Short Rep       Date:  2011-04-18

9.  A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet's Disease with Crohn's Disease-Like Anal Fistulas.

Authors:  Tsuyoshi Kobashigawa; Yuki Nanke; Masakazu Takazoe; Kuniko Iihara; Hisashi Yamanaka; Shigeru Kotake
Journal:  Clin Med Insights Case Rep       Date:  2014-04-27

Review 10.  Enteropathic spondyloarthritis: from diagnosis to treatment.

Authors:  Rosario Peluso; Matteo Nicola Dario Di Minno; Salvatore Iervolino; Francesco Manguso; Giuseppina Tramontano; Pasquale Ambrosino; Carmela Esposito; Antonella Scalera; Fabiana Castiglione; Raffaele Scarpa
Journal:  Clin Dev Immunol       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.